NASDAQ: ALVO
Alvotech Earnings Dates, Reports, Calls

Alvotech earnings were $96.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ALVO earnings report on Mar 31, 2025 announced Q1 2025 earnings of $109.7M, down 263.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALVO reported annual earnings of -$231.9M, with -58% growth.

ALVO earnings history

Current Revenue
$587.9M
Current Earnings
$96.5M
Current Profit Margin
16.4%

ALVO Return on Equity

Current Company
-23.2%
Current Industry
12.8%
Current Market
31.5%
ALVO's Return on Equity (-23.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ALVO undefined

Current Company
8.1%
Current Industry
6.9%
ALVO is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALVO announces earnings.

ALVO undefined

Current Company
26.1%
Current Industry
14.4%

ALVO vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALVO$288.04M$96.55MN/A$0.41
HCM$47.79M$37.73M-66.67%$0.20
AMRX$503.18M-$13.05MN/A-$0.04
PRGO$518.70M-$180.30MN/A-$1.31
BHC$2.85B-$40.00MN/A-$0.11

Alvotech Earnings Reports & History FAQ

What were Alvotech's earnings last quarter?

Alvotech (NASDAQ: ALVO) reported Q1 2025 earnings per share (EPS) of $0.39, up 143.82% year over year. Total ALVO earnings for the quarter were $109.68 million. In the same quarter last year, Alvotech's earnings per share (EPS) was -$0.89.

If you're new to stock investing, here's how to buy Alvotech stock.

Is Alvotech profitable or losing money?

As of the last Alvotech earnings report, Alvotech is currently profitable. Alvotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $96.55 million, a 119.53% decrease year over year.

What was ALVO's earnings growth in the past year?

As of Alvotech's earnings date in Q2 2025, Alvotech's earnings has grown year over year. ALVO earnings in the past year totalled $96.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.